Login / Signup

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

Kenneth H MayerKelly E SeatonYunda HuangNicole A GrunenbergAbby IsaacsMary A AllenJulie E LedgerwoodIan FrankMagdalena E SobieszczykLindsey R BadenBenigno RodriguezHong Van TieuGeorgia D TomarasAaron DealDerrick GoodmanRobert T BailerGuido FerrariRyan JensenJohn HuralBarney S GrahamJohn R MascolaLawrence CoreyDavid C Montefiorinull nullnull null
Published in: PLoS medicine (2017)
Clinical Trials Registration: NCT02165267.
Keyphrases
  • hiv infected
  • monoclonal antibody
  • antiretroviral therapy
  • hiv positive
  • hiv testing
  • human immunodeficiency virus
  • clinical trial
  • hepatitis c virus
  • hiv aids
  • men who have sex with men
  • high dose
  • low dose
  • phase ii